Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Research Grade Biosimilars

Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO) (HV974016)

Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)
Price(USD):
Spec:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HV974016
Description
_x005F_x000D_
_x005F_x000D_
_x005F_x000D_ _x005F_x000D_
_x005F_x000D_ _x005F_x000D_
Atezolizumab (HV974016) is a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation.
_x005F_x000D_ _x005F_x000D_
_x005F_x000D_
Highlights
_x005F_x000D_ _x005F_x000D_
    _x005F_x000D_
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • _x005F_x000D_
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
  • _x005F_x000D_
_x005F_x000D_
_x005F_x000D_ _x005F_x000D_
_x005F_x000D_
Resources
_x005F_x000D_ _x005F_x000D_ _x005F_x000D_
_x005F_x000D_
Species reactivityHuman
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host speciesHuman
IsotypeIgG1-kappa
Expression system Mammalian cells
Clonality Monoclonal
Target B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q9NZQ7
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesMPDL3280A, RG7446, 1380723-44-3
Background

Programmed cell death 1 ligand 1 (CD274/PD-L1) is a ~33 kDa protein. Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10). Can also act as a transcription coactivator: in response to hypoxia, translocates into the nucleus via its interaction with phosphorylated STAT3 and promotes transcription of GSDMC, leading to pyroptosis. CD274 is the therapeutic target of atezolizumab (Tecentriq) and durvalumab (Imfinzi).

_x005F_x000D_ _x005F_x000D_
1. Freeman, GJ. et al. (2000) The Journal of experimental medicine 192, 1027-34. PMID: 11015443
_x005F_x000D_ _x005F_x000D_
2. Mezzadra, R. et al. (2017) Nature 549, 106-110. PMID: 28813410
_x005F_x000D_ _x005F_x000D_
3. Burr, ML. et al. (2017) Nature 549, 101-105. PMID: 28813417
_x005F_x000D_ _x005F_x000D_
4. Huang, X. et al. (2019) Cancer immunology research 7, 1580-1590. PMID: 31399419
_x005F_x000D_ _x005F_x000D_
5. Kennedy, A. et al. (2023) The EMBO journal 42, e111556. PMID: 36727298
_x005F_x000D_ _x005F_x000D_
6. Dong, H. et al. (1999) Nature medicine 5, 1365-9. PMID: 10581077
_x005F_x000D_ _x005F_x000D_
7. Hou, J. et al. (2020) Nature cell biology 22, 1264-1275. PMID: 32929201
_x005F_x000D_
Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)

    SEC-HPLC

    SEC-HPLC detection for Research Grade Atezolizumab.

  • Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)

    Bioactivity

    Detects CD274/PD-L1/B7-H1 in indirect ELISAs.

  • Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Atezolizumab

  • Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)

    Flow Cytometry

    Flow-cytometry using anti-human CD274 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human CD274 monoclonal antibody (Catalog HV974016) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human PD-L1/B7-H1 Reference Antibody (Atezolizumab, RUO)

    Flow CytoMetry

    Flow-cytometry using FITC anti-human CD274 antibody. MDA-MB-231 cells were stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human CD274 monoclonal antibody (Catalog: HV974016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list